Search Results 241-250 of 8434 for Conduction

  1. Congenital heart disease in adults - Doctors and departments - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  2. A Study of the Effect of Ezogabine on Motor Neuron Excitability in Patients with Amyotrophic Lateral Sclerosis - Mayo Clinic

    Clinically significant conduction abnormalities on electrocardiogram or a known history of cardiac arrhythmia, myocardial infarction within the past 24 ...

  3. Evaluating Adult Patient Temperatures During Lower Spinal Surgery - Mayo Clinic

    The purpose of this study is to evaluate patients' temperatures after using one of two ventilator circuits (breathing systems): the ANAPOD™ Heat and ...

  4. VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM - Mayo Clinic

    No clinically significant cardiac conduction disorder on screening. Female patients of child-bearing potential must have a negative serum or urine pregnancy ...

  5. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  6. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  7. Physical Medicine and Rehabilitation - Tests and procedures - Mayo Clinic

    Nerve conduction studies; Nerve flossing; Nerve hydrodissection; Neural tensioning; Neurogenic bladder and bowel management; Neurological rehabilitation ...

  8. A Study to Evaluate AZD1775 in Women with Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma - Mayo Clinic

    - Conduction abnormality not controlled with pacemaker or medication - Significant ventricular or supraventricular arrhythmias 7. History of Torsades de ...

  9. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

    ... conduction system abnormalities. Prior to the first dose of study treatment, any electrocardiogram (ECG) abnormality at screening must be documented by the ...

  10. A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin amyloidosis - Mayo Clinic

    Current treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...